GlassScriptPhysician profile
Francisco G Colon
NPI 1770574410
$15,827.06
in general payments reported to CMS, 2019-2025
10 companies · $5,229 in 2025
The $5,229 reported for 2025 was more than what 93% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2020: $239 · 2021: $138 · 2022: $368 · 2023: $3,895 · 2024: $5,781 · 2025: $5,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $1,711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,193.68 |
| Food and Beverage | $1,711.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14,202.88 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $891.49 | 2019-2022 | |
| Revance Therapeutics, INC. | $528.09 | 2024-2025 | Daxxify |
| Mentor Worldwide LLC | $57.96 | 2023 | Mentor Cpx 2 Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $55.96 | 2023 | |
| Solta Medical, A Division of Bausch Health US, LLC | $27.15 | 2024 | |
| Motiva USA, LLC | $18.31 | 2025 | |
| Tepha INC | $17.05 | 2019 | |
| Tela Bio, INC. | $14.67 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Acelrx Pharmaceuticals, INC. | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francisco Colon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.